These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 9768682

  • 1. Therapeutic usefulness of wild-type p53 gene introduction in a p53-null anaplastic thyroid carcinoma cell line.
    Narimatsu M, Nagayama Y, Akino K, Yasuda M, Yamamoto T, Yang TT, Ohtsuru A, Namba H, Yamashita S, Ayabe H, Niwa M.
    J Clin Endocrinol Metab; 1998 Oct; 83(10):3668-72. PubMed ID: 9768682
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Inhibition of angiogenesis and tumorigenesis, and induction of dormancy by p53 in a p53-null thyroid carcinoma cell line in vivo.
    Nagayama Y, Shigematsu K, Namba H, Zeki K, Yamashita S, Niwa M.
    Anticancer Res; 2000 Oct; 20(4):2723-8. PubMed ID: 10953350
    [Abstract] [Full Text] [Related]

  • 4. p53 induced by ionizing radiation mediates DNA end-jointing activity, but not apoptosis of thyroid cells.
    Yang T, Namba H, Hara T, Takmura N, Nagayama Y, Fukata S, Ishikawa N, Kuma K, Ito K, Yamashita S.
    Oncogene; 1997 Apr 03; 14(13):1511-9. PubMed ID: 9129141
    [Abstract] [Full Text] [Related]

  • 5. Effects of exogenous p53 transduction in thyroid tumor cells with different p53 status.
    Moretti F, Nanni S, Farsetti A, Narducci M, Crescenzi M, Giuliacci S, Sacchi A, Pontecorvi A.
    J Clin Endocrinol Metab; 2000 Jan 03; 85(1):302-8. PubMed ID: 10634403
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effects of p53-expressing adenovirus on the chemosensitivity and differentiation of anaplastic thyroid cancer cells.
    Blagosklonny MV, Giannakakou P, Wojtowicz M, Romanova LY, Ain KB, Bates SE, Fojo T.
    J Clin Endocrinol Metab; 1998 Jul 03; 83(7):2516-22. PubMed ID: 9661637
    [Abstract] [Full Text] [Related]

  • 8. Effect of wild-type and mutant E-cadherin on cell proliferation and responsiveness to the chemotherapeutic agents cisplatin, etoposide, and 5-fluorouracil.
    Fricke E, Hermannstädter C, Keller G, Fuchs M, Brunner I, Busch R, Höfler H, Becker KF, Luber B.
    Oncology; 2004 Jul 03; 66(2):150-9. PubMed ID: 15138368
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Modulation of retrovirally driven therapeutic genes by mutant TP53 in anaplastic thyroid carcinoma.
    Barzon L, Gnatta E, Castagliuolo I, Trevisan M, Moretti F, Pontecorvi A, Boscaro M, Palù G.
    Cancer Gene Ther; 2005 Apr 03; 12(4):381-8. PubMed ID: 15650765
    [Abstract] [Full Text] [Related]

  • 11. Targeting the replication of adenovirus to p53-defective thyroid carcinoma with a p53-regulated Cre/loxP system.
    Nagayama Y, Nishihara E, Namba H, Yokoi H, Hasegawa M, Mizuguchi H, Hayakawa T, Hamada H, Yamashita S, Niwa M.
    Cancer Gene Ther; 2001 Jan 03; 8(1):36-44. PubMed ID: 11219492
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Plitidepsin has a cytostatic effect in human undifferentiated (anaplastic) thyroid carcinoma.
    Bravo SB, García-Rendueles ME, Seoane R, Dosil V, Cameselle-Teijeiro J, López-Lázaro L, Zalvide J, Barreiro F, Pombo CM, Alvarez CV.
    Clin Cancer Res; 2005 Nov 01; 11(21):7664-73. PubMed ID: 16278386
    [Abstract] [Full Text] [Related]

  • 15. Mutation of p53 in head and neck squamous cell carcinoma correlates with Bcl-2 expression and increased susceptibility to cisplatin-induced apoptosis.
    Andrews GA, Xi S, Pomerantz RG, Lin CJ, Gooding WE, Wentzel AL, Wu L, Sidransky D, Grandis JR.
    Head Neck; 2004 Oct 01; 26(10):870-7. PubMed ID: 15390206
    [Abstract] [Full Text] [Related]

  • 16. CCAAT/Enhancer-binding protein-homologous protein sensitizes to SU5416 by modulating p21 and PI3K/Akt signal pathway in FRO anaplastic thyroid carcinoma cells.
    Kim SH, Kang JG, Kim CS, Ihm SH, Choi MG, Yoo HJ, Lee SJ.
    Horm Metab Res; 2013 Jan 01; 45(1):9-14. PubMed ID: 22918703
    [Abstract] [Full Text] [Related]

  • 17. Establishment of anaplastic thyroid carcinoma cell lines useful for analysis of chemosensitivity and carcinogenesis.
    Asakawa H, Kobayashi T, Komoike Y, Yanagawa T, Takahashi M, Wakasugi E, Maruyama H, Tamaki Y, Matsuzawa Y, Monden M.
    J Clin Endocrinol Metab; 1996 Oct 01; 81(10):3547-52. PubMed ID: 8855799
    [Abstract] [Full Text] [Related]

  • 18. Involvement of wild-type p53 in radiation-induced c-Jun N-terminal kinase activation in human thyroid cells.
    Shklyaev SS, Namba H, Sautin Y, Mitsutake N, Nagayama Y, Ishikawa N, Ito K, Zeki K, Yamashita S.
    Anticancer Res; 2001 Oct 01; 21(4A):2569-75. PubMed ID: 11724323
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.